Thymopentin ameliorates experimental colitis via inhibiting neutrophil extracellular traps
International Immunopharmacology · 2023-11 · 124 · 110898
DOI: 10.1016/j.intimp.2023.110898 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2023-11. Verfasst von Dongxing Cao und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, Baoshan Branch, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200444, China; Department…. Hauptthemen laut MEDLINE: Extracellular Traps, Colitis, Neutrophils, Thymopentin. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
BACKGROUND: The long-term prognosis of Crohn's disease (CD) remains unsatisfactory. Therefore, we assessed the therapeutic effect of thymopentin (TP5) in a mouse model of 2,4,6-trinitrobenzene sulfonic acid (TNBS)-induced colitis, which mimics CD, and analyzed its impact on neutrophil extracellular traps (NETs). METHODS: NET markers, including myeloperoxidase (MPO), neutrophil elastase (NE), citrullinated histone H3 (CitH3), peptidyl arginine deiminase IV (PAD4), and double-stranded DNA (dsDNA) were assessed by immunostaining and enzyme-linked immunosorbent assay. NET formation was evaluated in vitro. Neoseptin 3, a specific NET agonist, was used to reverse the effect of TP5 on TNBS-induced colitis. The action mechanism of TP5 was investigated using RNA-seq. RESULTS: TP5 ameliorated weight loss (P < 0.001), disease activity index (DAI) (P = 0.05), colon shrinkage (P = 0.04), and elevated levels of tumor necrosis factor-alpha (TNF-α), interleukin (IL)-1β, IL-6, and neutrophils in the TNBS group. The TNBS group exhibited increased MPO, NE, CitH3, PAD4, dsDNA and MPO-DNA levels (all P < 0.001), which decreased after TP5 administration (P = 0.01, P < 0.001, P < 0.001, P < 0.001, P = 0.02, and P = 0.02 respectively). Tissue CitH3 levels were positively correlated with DAI and TNF-α levels (P < 0.05). Furthermore, phorbol 12-myristate 13-acetate-stimulated NET formation increased by 1.8-, 2.8-, and 2.3-fold in vitro in the control, TNBS + saline, and TNBS + TP5 groups, respectively. Neoseptin 3 significantly reversed the effect of TP5. RNA-seq revealed potential pathways underlying the effect of TP5. CONCLUSION: TP5 effectively ameliorated colitis by suppressing NETs in the experimental CD model.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of General Surgery, Baoshan Branch, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200444, China; Department of Gastrointestinal Surgery, Ren Ji Hospital, School of Medicine, Sha…
- Laboratory of Medicine, Baoshan Branch, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200444, China. Electronic address: qianky@renjibs.com.
- Department of Gastrointestinal Surgery, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, China. Electronic address: yangnailin@renji.com.
- Laboratory Medicine, Baoshan Branch, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200444, China. Electronic address: joanna209209@163.com.
- Department of General Surgery, Baoshan Branch, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200444, China. Electronic address: wangxh@renjibs.com.
- Division of Gastroenterology and Hepatology, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, China. Electronic address: zhumingming@renji.com.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Cao, D., Qian, K., Yang, N., Xu, G., Wang, X., Zhu, M., Wang, Y., Li, H., Shen, J., Zhang, Y., & Cui, Z. (2023). Thymopentin ameliorates experimental colitis via inhibiting neutrophil extracellular traps. International Immunopharmacology, 124, 110898. https://doi.org/10.1016/j.intimp.2023.110898
Vancouver
Cao D, Qian K, Yang N, Xu G, Wang X, Zhu M, et al. Thymopentin ameliorates experimental colitis via inhibiting neutrophil extracellular traps. International Immunopharmacology. 2023;124:110898. doi:10.1016/j.intimp.2023.110898
BibTeX
@article{Cao2023,
author = {Cao, Dongxing and Qian, Keyu and Yang, Nailin and Xu, Gang and Wang, Xiaohui and Zhu, Mingming and Wang, Yangyang and Li, Han and Shen, Jun and Zhang, Ye and Cui, Zhe},
title = {Thymopentin ameliorates experimental colitis via inhibiting neutrophil extracellular traps},
journal = {International Immunopharmacology},
year = {2023},
volume = {124},
pages = {110898},
doi = {10.1016/j.intimp.2023.110898}
}
EUVIMED